European Hematology Association 2022 (EHA) Congress
June 09, 2022 ‐ June 12, 2022 in Vienna, Austria
The European Hematology Association 2022 (EHA) Congress will take place both virtually and in-person in Vienna, Austria, from June 9 to 12, 2022.
Cellectis will present two posters at the European Hematology Association 2022 annual congress.
Mark Frattinni, MD, PhD will present a poster on BALLI-01, evaluating UCART22 in relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
Beatriz Aranda Orgilles will present a poster on UCART20x22 Cellectis’ first allogeneic dual CAR T-cell product candidate being developed for patients with relapsed or refractory non-Hodgkin lymphoma (r/r NHL).
Presentation information is below:
UCART20x22
Title: Pre-Clinical Proof of Concept Demonstrates Robust Activity Of UCART20x22 Dual CART T-Cells For The Treatment Of B-Cell Malignancies
Session date and time: Friday, June 10, 16:30 - 17:45 CEST
Final Abstract Code: P1420
Presenting Author: Beatriz Aranda Orgilles, PhD
BALLI-01
Title: Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR T-Cell Product, in Adult Patients with Relapsed or Refractory CD22+ B-Cell Acute Lymphoblastic Leukemia
Session Date and Time: Friday, June 10 16:30 - 17:45 CEST
Final Abstract code: P1451
Presenting Author: Mark Frattini, MD, PhD
Posters will be made available on the Cellectis website on June 10th.